Akari Therapeutics to Highlight RNA-Splicing ADC Payload Strategy
Akari Therapeutics plans to discuss the potential of RNA-splicing payloads to drive broad anti-tumor effects at the 3rd Annual ADC Payload Summit.
Akari Therapeutics plans to discuss the potential of RNA-splicing payloads to drive broad anti-tumor effects at the 3rd Annual ADC Payload Summit.